FDA DEVICE FACTS
LIAISON PLEX Gastrointestinal Flex Assay
Luminex Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The LIAISON PLEX Gastrointestinal Flex Assay is an automated qualitative multiplex test for simultaneous detection and identification of pathogenic bacteria, viruses, and parasites in liquid or soft stool from symptomatic individuals. Cary-Blair or modified Cary-Blair medium is permitted for all targets; alcohol-based, formalin-free parasite fixative such as EcoFix or Total-Fix is additionally permitted for parasite testing. On the automated LIAISON PLEX System, reverse transcription, PCR, and array hybridization detect Campylobacter species; C. difficile tcdA/tcdB; ETEC LT/ST; Plesiomonas shigelloides; Salmonella species; STEC stx1 and stx2; Shigella/EIEC; Vibrio cholerae; V. parahaemolyticus/V. vulnificus; Yersinia enterocolitica; adenovirus F40/41; astrovirus; norovirus GI/GII; rotavirus A; sapovirus I/II/IV/V; Blastocystis; Cryptosporidium; Cyclospora cayetanensis; Dientamoeba fragilis; Entamoeba histolytica; Giardia lamblia/intestinalis/duodenalis; Microsporidia including Encephalitozoon hellem, E. intestinalis, and Enterocytozoon bieneusi; and Strongyloides stercoralis. The assay aids diagnosis of specific gastrointestinal-illness agents and results must be used with clinical, laboratory, and epidemiological information. It is not for monitoring these infections or C. difficile infection. Concomitant culture is required for organism recovery and further typing of bacterial agents. Results must not be the sole basis for diagnosis, treatment, or other patient management. A confirmed positive does not exclude undetected coinfection and may not identify the sole or definitive cause. A negative in clinically compatible gastroenteritis may reflect an undetected pathogen or a noninfectious cause such as ulcerative colitis, irritable bowel syndrome, or Crohn's disease.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。